AzTrials
AzTrials

Pain After the Surgical Extraction of Third MolarsEarly Phase 1NCT05614440

The Effects of Tramadol Combined With Local Anesthesia on Pain After the Surgical Extraction of Third Molars

A Early Phase 1 study testing Local anesthetic + tramadol hydrochloride and Only local anesthetic in people with Pain After the Surgical Extraction of Third Molars, run by Marmara University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study was to assess the efficacy of local anesthetic and tramadol combinations in the prevention of pain after the surgical extraction of third molars. Read more about this study

Who is it for?
Ages 18 to 50 years
What is being tested?
Local anesthetic + tramadol hydrochloride and Only local anesthetic
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
No sites listed yet
Study dates
1 May 2012to 1 Jan 2014
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Score of ASA I-II (American Society of Anesthesiologists Physical Status I or II)
  • Patient weights were less than 60 kg

Who cannot join

  • Subjects who had taken a sedative, tranquillizer, or analgesic medication within the last 24 h,
  • Sensitive to tramadol,
  • Patients who needed an extra dose of anesthetic solution during the surgery

About this study

The purpose of this study was to assess the efficacy of local anesthetic and tramadol combinations in the prevention of pain after the surgical extraction of third molars.

Read the detailed description

The surgical removal of impacted third molar teeth is a procedure that is frequently encountered in oral and maxillofacial surgery practices. Pain following these operations is one of the most important factors affecting patient satisfaction. Several pain-management strategies are available. An alternative approach to pain control is to maximize drug levels at the tissue injury site by administering drugs locally.

Tramadol is a centrally acting opioid that provides good analgesia. It reduces the transmission of pain impulses by inhibiting serotonin and norepinephrine re-uptake. In addition to the systemic analgesic effects, the local anesthetic effects of tramadol on the peripheral nerves have been presented in multiple clinical and laboratory studies.

The aim of this study is to test the clinical efficacy of local anesthetic and tramadol combinations during and after the surgical extraction of the lower third molars.

Being tested
Local anesthetic + tramadol hydrochloride, Only local anesthetic
Keywords
tramadol, third molar extraction, analgesia
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Local anesthetic + tramadol hydrochlorideDrug

    Also called Articaine

    Using tramadol hydrochloride and articain HCL for inferior alveolar nerve block

  • Only local anestheticDrug

    Using articain HCL for inferior alveolar nerve block

Study groups in NCT05614440
Study groupRoleWhat they receive
Only local anesthetic groupActive comparatorNot described
Receives: Drug: Only local anesthetic
Tramadol groupExperimentalNot described
Receives: Drug: Local anesthetic + tramadol hydrochloride

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in pain

    Postoperative pain was assessed using a Visual Analogue Scale (VAS) ranging from the absence of pain (score 0) to the most severe pain imaginable. VAS values were taken from the patient during; post-op 10 minutes, hour 1, hour 2, hour 4, hour 6, hour 12, hour 24, hour 48.

    Measured: 48 hours

Secondary outcomes (2)
  1. Change in mean blood pressure

    Change in mean blood pressure assessed in baseline (after anesthetic injection), minute 10minute, minute 20, minute 30, minute 40, minute 50, minute 60.

    Measured: 60 minutes

  2. Change in heart rate

    Change in heart rate assessed in baseline (after anesthetic injection), minute 10minute, minute 20, minute 30, minute 40, minute 50, minute 60.

    Measured: 60 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2022
  2. Study start1 May 2012
  3. Primary completion1 Nov 2013
  4. Study completion1 Jan 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
The patients were randomly divided into the following two groups using the sealed envelope method.
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05614440
Sponsor's protocol ID
153-2011
Status last verified
Nov 2022
First submitted
31 Oct 2022
Last updated
14 Nov 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Deshpande AA, Hemavathy OR, Krishnan S, Ahmed R. Comparison of effect of intra socket ketamine and tramadol on postoperative pain after mandibular third molar surgery. Natl J Maxillofac Surg. 2022 Jan-Apr;13(1):95-98. doi: 10.4103/njms.NJMS_141_20. Epub 2022 Apr 20.

    PubMed 35911818
  • Vallecillo C, Vallecillo-Rivas M, Galvez R, Vallecillo-Capilla M, Olmedo-Gaya MV. ANALGESIC EFFICACY OF TRAMADOL/DEXKETOPROFEN VS IBUPROFEN AFTER IMPACTED LOWER THIRD MOLAR EXTRACTION: A RANDOMIZED CONTROLLED CLINICAL TRIAL. J Evid Based Dent Pract. 2021 Dec;21(4):101618. doi: 10.1016/j.jebdp.2021.101618. Epub 2021 Jul 28.

    PubMed 34922724
  • Iqbal AM, Shetty P. Effect of Submucosal Injection of Tramadol on Postoperative Pain After Third Molar Surgery. J Oral Maxillofac Surg. 2019 Sep;77(9):1752-1759. doi: 10.1016/j.joms.2019.03.029. Epub 2019 Mar 29.

    PubMed 31026419
  • Afat IM, Gonul O, Satilmis T. Tramadol combined with local anesthesia for postoperative pain in third molar surgery. BMC Oral Health. 2025 Oct 14;25(1):1610. doi: 10.1186/s12903-025-07011-0.

    PubMed 41088090

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Local anesthetic + tramadol hydrochloride and Only local anesthetic in people with Pain After the Surgical Extraction of Third Molars, run by Marmara University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in pain (time frame: 48 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05614440, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in